PlatinumReception SponsorEvent SponsorRegistration & LanyardPlatinum Event PartnerEvent Partners

Life Sciences Conferences

The Burrill Personalized Medicine Meeting


Day One - October 3, 2011

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 9:30 a.m.
Welcome and Personalized Medicine Industry Update
An overview of the current state of the personalized medicine industry in the context of a turbulent, challenging economy, and in the “post healthcare reform environment”
G. Steven Burrill, CEO, Burrill & Company

9:30 – 9:45 a.m.

9:45 – 10:30 a.m.
We are well beyond the concept of the 3 Ps (Personalized, Predictive, & Preemptive medicine) -- Where are we really with:

“The Science” - Keynote Presentation
Ralph Snyderman, M.D., Chancellor Emeritus, Duke University

10:30 a.m. – 11:45 p.m.
Panel: “The Business”
Pierre Cassigneul, President and Chief Executive Officer, XDx
Deb Kilpatrick, SVP of Commercial Operations, CardioDx
Matthew McManus, MD, PhD, President & CEO, PrimeraDx
Mickey Urdea, PhD, Co-founder, Chairman and CSO, Tethys Bioscience
Moderator: Ralph Snyderman, M.D., Chancellor Emeritus, Duke University 

11:45 – 1:00 p.m.
‘Conversations with Experts’ Luncheon

1:00 – 2:00 p.m.
Keynote Presentation: “It from Bits”: Managing massive data as a critical challenge for biomedical R&D and healthcare delivery.
Dr. George Poste, DVM, PhD, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University
Introduced by: G. Steven Burrill, CEO, Burrill & Company 

2:00 – 3:00 p.m.
Panel: Is Personalized Medicine just the next generation of MDx? Where is the real action?
Stephen Little, Vice President Personalized Healthcare, Qiagen
Matthew Rosamond, Director - Personalized Medicine Practice, PwC
Brad Stewart, Chairman, CEO and President, Cylex
Moderator: Bryant Fong, Managing Director, Burrill & Company

3:00 – 3:15 p.m.

3:15 – 3:45 p.m.
Company Presentation:
Aris Persidis, PhD, President, Co-Founder, Biovista
Dave Albert, MD, Founder, AliveCor
Introduced by: G. Steven Burrill, CEO, Burrill & Company

3:45 – 4:45 p.m.
Panel: Let’s look at Cancer – What’s happening in PM?
Michael Cantor, Director, Healthcare Informatics, Pfizer, Inc.
Carlos Santos, Chief Scientific Officer, Biovest International, Inc.
Moderator: Jay M. Tenenbaum, Ph.D. Chairman, CEO, and Chief Scientist, CollabRx

4:45 – 5:45 p.m.
Keynote Presentation: Ion Torrent Powered Genetic Medicine
Gregory Lucier, Chairman & CEO, Life Technologies
Introduced by: G. Steven Burrill, CEO, Burrill & Company

5:45 p.m.
Meeting Wrap-Up (Day One)
G. Steven Burrill, CEO, Burrill & Company

5:45 – 7:30 p.m.
Networking Reception
Sponsored By: Fenwick & West LLP

Day 2 - October 4, 2011

7:30 – 8:15 a.m.

8:15 – 9:15 a.m.
Keynote Presentation: The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine
Kevin Davies, Science Writer, Editor-in-Chief of "Bio-IT World" and Author of "The $1000 Genome Introduced by: G. Steven Burrill, CEO, Burrill & Company

9:15 – 10:15 a.m.
Panel: The Revolutionary War: The Battle to Dominate Next-Gen Sequencing
Clifford Reid, CEO, Complete Genomics
Jay Flatley, CEO, Illumina, Inc.
Hugh Martin, CEO, Pacific Biosciences
Paul Billings, Chief Medical Officer, Life Technologies
Moderator: G. Steven Burrill, CEO, Burrill & Company

10:15 – 10:30 a.m.

10:30– 10:45 a.m.
Presentation: The Role of Companion Diagnostics in Moving Pharmacogenomics Forward
Joshua Cohen, Research Associate Professor of Medicine, Tufts University

10:45– 11:45 a.m.
Keynote Presentation: Reengineering the Therapeutic Development Pipeline
Francis Collins, MD, PhD, Director, NIH
Introduced by: G. Steven Burrill, CEO, Burrill & Company

11:45 a.m. – 12:45 p.m.
Panel: Consumer Protection or Government Intrusion: Is Regulation appropriate? Is it different in Europe? Japan? Are companies moving away from “betting the company” on the FDA?
Dietrich Stephan, President and CEO, Ignite Institute
David Gollaher, President and Chief Executive Officer, CHI-California Healthcare Institute
Moderator: Michael Shuster, PhD, JD, Partner and Co-chair of the Life Sciences Group, at Fenwick & West LLP

12:45 p.m.
Meeting Wrap-Up
G. Steven Burrill, CEO, Burrill & Company

1:00 p.m.